CULTURE WOUND POSITIVE side effect
What is CULTURE WOUND POSITIVE ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
CULTURE WOUND POSITIVE and Recently Reported Side Effects
CULTURE WOUND POSITIVE and 15 most Active Side Effect polls
CULTURE WOUND POSITIVE and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with CULTURE WOUND POSITIVE
AMNESTEEM AVONEX BEVACIZUMAB CARBOPLATIN CYCLOPHOSPHAMIDE CYTARABINE DACOGEN DICLOFENAC FLUCONAZOLE METHYLENE NATALIZUMAB RENAGEL SORAFENIB SUTENT TEMODAL VIVITROLSorafenib Side Effects Report #5652889-6
Consumer or non-health professional from UNITED STATES reported SORAFENIB problem on Feb 28, 2008. Female patient was diagnosed with medullary thyroid cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: culture wound positive, diarrhoea, hepatic failure, hepatotoxicity, renal failure, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CALCITRATE, VITAMIN D, SYNTHROID. Patient was hospitalized. Patient died on 12/22/2007.
Sorafenib Side Effects Report #5655325-9
SORAFENIB problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2008. Female patient was diagnosed with medullary thyroid cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: culture wound positive, hepatic failure, hepatotoxicity, hypergammaglobulinaemia, renal failure, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CALCITRATE, VITAMIN D, SYNTHROID. Patient was hospitalized. Patient died on 12/22/2007.
Amnesteem Side Effects Report #5618872-1
Consumer or non-health professional from UNITED STATES reported AMNESTEEM problem on Jan 24, 2008. Female patient, 16 years of age, was diagnosed with acne and was treated with AMNESTEEM. After drug was administered, patient experienced the following problems/side effects: culture wound positive, genital lesion, streptococcal infection, . AMNESTEEM dosage: 40 MG; DAILY; ORAL. Patient was hospitalized. Patient recovered.
Vivitrol Side Effects Report #5586169-4
VIVITROL problem was reported by a Health Professional from UNITED STATES on Nov 19, 2007. Female patient, weighting 217.0 lb, was diagnosed with alcohol abuse and was treated with VIVITROL. After drug was administered, patient experienced the following problems/side effects: culture wound positive, enterobacter infection, injection site abscess, treatment failure, wound infection pseudomonas, . VIVITROL dosage: 380 MG 1X/MONTH,. During the same period patient was treated with NEXIUM. Patient was hospitalized and became disabled. Patient recovered.
Vivitrol Side Effects Report #5591460-1
Physician from UNITED STATES reported VIVITROL problem on Dec 28, 2007. Female patient, weighting 225.0 lb, was diagnosed with alcoholism and was treated with VIVITROL. After drug was administered, patient experienced the following problems/side effects: culture wound positive, injection site abscess, injection site infection, injection site pain, injection site pruritus, injection site reaction, streptococcal infection, . VIVITROL dosage: 380 MG 1X/MONTH INTRAMUSCULAR. During the same period patient was treated with LAMICTAL, ANTIHYPERTENSIVES, ORAL ANTIDIABETICS. Patient was hospitalized. Patient recovered.
Vivitrol Side Effects Report #5599989-7
VIVITROL problem was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Female patient, weighting 217.0 lb, was diagnosed with alcohol abuse and was treated with VIVITROL. After drug was administered, patient experienced the following problems/side effects: culture wound positive, enterobacter infection, injection site abscess, injection site infection, injection site necrosis, no therapeutic response, scar, wound infection pseudomonas, . VIVITROL dosage: (380 MG 1X/MONTH). During the same period patient was treated with NEXIUM. Patient was hospitalized and became disabled. Patient recovered.
Sutent Side Effects Report #5503231-2
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Oct 23, 2007. Female patient, weighting 156.1 lb, was diagnosed with breast cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: culture wound positive, gastroenteritis proteus, hyperplasia, infected skin ulcer, pseudomonas infection, skin graft, skin infection, skin odour abnormal, staphylococcal infection, . SUTENT dosage: unknown. During the same period patient was treated with PACLITAXEL, LOPERAMIDE, EPOETIN ALFA, NEUPOGEN, ULTRAM, ESOMEPRAZOLE MAGNESIUM, FEXOFENADINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Carboplatin Side Effects Report #5416458-5
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 13, 2007. Female patient, weighting 165.3 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: culture wound positive, erythema, pulmonary embolism, rectal haemorrhage, staphylococcal infection, . CARBOPLATIN dosage: 628 MG. During the same period patient was treated with TAXOTERE, TAXOL. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5648546-2
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 03, 2008. Female patient, weighting 209.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, culture wound positive, eating disorder, hepatitis b, purulent discharge, staphylococcal infection, wound secretion, . CYCLOPHOSPHAMIDE dosage: 1200 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Methylene Side Effects Report #5663780-3
METHYLENE BLUEECTION problem was reported by a Physician from UNITED STATES on Mar 04, 2008. Female patient was diagnosed with lymphadenopathy and was treated with METHYLENE BLUEECTION. After drug was administered, patient experienced the following problems/side effects: blister, culture wound positive, necrosis, pain, soft tissue infection, staphylococcal infection, wound infection pseudomonas, . METHYLENE BLUEECTION dosage: unknown. Patient recovered.
Dacogen Side Effects Report #5599266-4
Physician from UNITED STATES reported DACOGEN problem on Jan 07, 2008. Male patient, 62 years of age, weighting 202.0 lb, was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: cellulitis, culture wound positive, haematoma, open wound, pancytopenia, staphylococcal infection, . DACOGEN dosage: 42, MG, 1 IN 1 D, INTRAVENOUS; 32 MG, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SYNTHROID, PRILOSEC, PROCTOSAL, METOPROLOL TARTRATE, FENTANYL, PHOSPHORUS, OXYCODONE. Patient recovered.
Diclofenac Side Effects Report #5569945-3
DICLOFENAC problem was reported by a Physician from INDIA on Dec 06, 2007. Male patient, 29 years of age, was treated with DICLOFENAC. After drug was administered, patient experienced the following problems/side effects: blister, culture wound positive, embolia cutis medicamentosa, eschar, pain, staphylococcal identification test positive, ulcer, . DICLOFENAC dosage: unknown. During the same period patient was treated with ANTIVENIN. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5293954-5
Health Professional from UNITED STATES reported NATALIZUMAB problem on Mar 27, 2007. Female patient, 28 years of age, weighting 280.0 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: bacterial infection, culture wound positive, decubitus ulcer, deep vein thrombosis, neurogenic bladder, urinary tract infection, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with WELLBUTRIN, LEXAPRO, CATAPRES, BACLOFEN, MACRODANTIN, BACTRIM, ZANAFLEX. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5652741-6
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2008. Female patient, weighting 209.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, bedridden, culture wound positive, hepatic failure, hepatitis b, hepatitis fulminant, hypoxia, metabolic disorder, oral intake reduced, . CYCLOPHOSPHAMIDE dosage: 1200 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Renagel Side Effects Report #5567578-6
Physician from TAIWAN, PROVINCE OF CHINA reported RENAGEL problem on Dec 13, 2007. Female patient, 59 years of age, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: bacteroides infection, coma, culture wound positive, diabetic foot infection, escherichia infection, gangrene, leg amputation, septic shock, staphylococcal infection, . RENAGEL dosage: unknown. Patient was hospitalized and became disabled. Patient died on 10/23/2007.
Cytarabine Side Effects Report #5449897-7
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient, weighting 141.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, cellulitis, culture wound positive, erythema, febrile neutropenia, gangrene, haemoglobin decreased, hypotension, impaired healing, . CYTARABINE dosage: 3000 MG. During the same period patient was treated with ETOPOSIDE, IFOSFAMIDE, ATIVAN, COMPAZINE, LEXAPRO, LIDOCAINE VISCOUS ORAL SPRAY, NEUPOGEN, NYSTATIN. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5470298-X
Health Professional from UNITED STATES reported NATALIZUMAB problem on Sept 10, 2007. Male patient, 57 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, cellulitis, culture wound positive, infected skin ulcer, klebsiella infection, no therapeutic response, osteopenia, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with BACLOFEN, PROZAC, NITROFURANTOIN, BENADRYL, FLONASE, AMBIEN. Patient was hospitalized. Patient recovered.
Fluconazole Side Effects Report #5470865-3
FLUCONAZOLE problem was reported by a Consumer or non-health professional from ITALY on Sept 10, 2007. Male patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with FLUCONAZOLE. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, blood culture positive, culture wound positive, staphylococcal infection, toxic epidermal necrolysis, . FLUCONAZOLE dosage: unknown. During the same period patient was treated with ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5443124-2
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Aug 22, 2007. Male patient, 64 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: blood disorder, burn infection, culture wound positive, impaired healing, scar, skin graft, staphylococcal infection, urinary tract infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5401838-4
TEMODAL problem was reported by a Physician from UNITED KINGDOM on July 20, 2007. Male patient, 65 years of age, weighting 205.0 lb, was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: bacillus infection, cellulitis, culture wound positive, glioblastoma, malignant neoplasm progression, pseudomonas infection, sepsis, . TEMODAL dosage: 200 MG; ; PO. During the same period patient was treated with CYCLIZINE, WARFARIN. Patient was hospitalized. Patient died on 04/12/2007.
Temodal Side Effects Report #5401838-4
Physician from UNITED KINGDOM reported TEMODAL problem on July 20, 2007. Male patient, 65 years of age, weighting 205.0 lb, was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: bacillus infection, cellulitis, culture wound positive, glioblastoma, malignant neoplasm progression, pseudomonas infection, sepsis, . TEMODAL dosage: 200 MG; ; PO. During the same period patient was treated with CYCLIZINE, WARFARIN. Patient was hospitalized. Patient died on 04/12/2007.
Temodal Side Effects Report #5340070-X
TEMODAL problem was reported by a Physician from UNITED KINGDOM on May 21, 2007. Male patient, 65 years of age, weighting 205.0 lb, was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: bacterial infection, cellulitis, culture wound positive, glioblastoma, pseudomonas infection, sepsis, . TEMODAL dosage: 200MG, PO. During the same period patient was treated with CYCLIZINE, WARFARIN. Patient was hospitalized. Patient died on 04/12/2007.
Bevacizumab Side Effects Report #5259969-8
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Feb 23, 2007. Female patient, 66 years of age, weighting 220.9 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cellulitis, culture wound positive, diphtheria, haematocrit decreased, haemoglobin decreased, heart rate increased, pseudomonas infection, purulent discharge, . BEVACIZUMAB dosage: 1590 MG, Q3W, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, CALCIUM. Patient was hospitalized. Patient recovered.